Locke J - Search Results

1

Pomegranate extracts impact the androgen biosynthesis pathways in prostate cancer models in vitro and in vivo.

Ming DS, Pham S, Deb S, Chin MY, Kharmate G, Adomat H, Beheshti EH, Locke J, Guns ET. Ming DS, et al. Among authors: locke j. J Steroid Biochem Mol Biol. 2014 Sep;143:19-28. doi: 10.1016/j.jsbmb.2014.02.006. Epub 2014 Feb 22. J Steroid Biochem Mol Biol. 2014. PMID: 24565566

2

Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer.

Locke JA, Guns ES, Lubik AA, Adomat HH, Hendy SC, Wood CA, Ettinger SL, Gleave ME, Nelson CC. Locke JA, et al. Cancer Res. 2008 Aug 1;68(15):6407-15. doi: 10.1158/0008-5472.CAN-07-5997. Cancer Res. 2008. PMID: 18676866

3

A novel communication role for CYP17A1 in the progression of castration-resistant prostate cancer.

Locke JA, Fazli L, Adomat H, Smyl J, Weins K, Lubik AA, Hales DB, Nelson CC, Gleave ME, Tomlinson Guns ES. Locke JA, et al. Prostate. 2009 Jun 15;69(9):928-37. doi: 10.1002/pros.20940. Prostate. 2009. PMID: 19267349

4

Steroidogenesis inhibitors alter but do not eliminate androgen synthesis mechanisms during progression to castration-resistance in LNCaP prostate xenografts.

Locke JA, Nelson CC, Adomat HH, Hendy SC, Gleave ME, Guns ES. Locke JA, et al. J Steroid Biochem Mol Biol. 2009 Jul;115(3-5):126-36. doi: 10.1016/j.jsbmb.2009.03.011. Epub 2009 Apr 5. J Steroid Biochem Mol Biol. 2009. PMID: 19442514

5

Arachidonic acid activation of intratumoral steroid synthesis during prostate cancer progression to castration resistance.

Locke JA, Guns ES, Lehman ML, Ettinger S, Zoubeidi A, Lubik A, Margiotti K, Fazli L, Adomat H, Wasan KM, Gleave ME, Nelson CC. Locke JA, et al. Prostate. 2010 Feb 15;70(3):239-51. doi: 10.1002/pros.21057. Prostate. 2010. PMID: 19790237

6

Alterations in cholesterol regulation contribute to the production of intratumoral androgens during progression to castration-resistant prostate cancer in a mouse xenograft model.

Leon CG, Locke JA, Adomat HH, Etinger SL, Twiddy AL, Neumann RD, Nelson CC, Guns ES, Wasan KM. Leon CG, et al. Prostate. 2010 Mar 1;70(4):390-400. doi: 10.1002/pros.21072. Prostate. 2010. PMID: 19866465

7

Prostate cancer: finasteride extends PSA doubling time during intermittent hormone therapy.

Locke JA, Bruchovsky N. Locke JA, et al. Can J Urol. 2010 Jun;17(3):5162-9. Can J Urol. 2010. PMID: 20566007

8

Insulin increases de novo steroidogenesis in prostate cancer cells.

Lubik AA, Gunter JH, Hendy SC, Locke JA, Adomat HH, Thompson V, Herington A, Gleave ME, Pollak M, Nelson CC. Lubik AA, et al. Cancer Res. 2011 Sep 1;71(17):5754-64. doi: 10.1158/0008-5472.CAN-10-2470. Epub 2011 Jul 11. Cancer Res. 2011. PMID: 21747118 Free article.

9

Allelic loss of the loci containing the androgen synthesis gene, StAR, is prognostic for relapse in intermediate-risk prostate cancer.

Locke JA, Zafarana G, Malloff CA, Lam WL, Sykes J, Pintilie M, Ramnarine VR, Meng A, Ahmed O, Jurisica I, Guns ET, van der Kwast T, Milosevic M, Bristow RG. Locke JA, et al. Prostate. 2012 Sep 1;72(12):1295-305. doi: 10.1002/pros.22478. Epub 2011 Dec 27. Prostate. 2012. PMID: 22213075 Clinical Trial.

10

Next generation biomarkers in prostate cancer.

Locke JA, Black PC. Locke JA, et al. Front Biosci (Landmark Ed). 2016 Jan 1;21(2):328-42. doi: 10.2741/4391. Front Biosci (Landmark Ed). 2016. PMID: 26709776 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

803 results

Search Page

Filters